215 related articles for article (PubMed ID: 17665321)
1. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 2.
Walker K
IDrugs; 2007 Aug; 10(8):517-9. PubMed ID: 17665321
[No Abstract] [Full Text] [Related]
2. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 4.
Walker K; Kibble A; Shumoogam J
IDrugs; 2007 Aug; 10(8):523-6. PubMed ID: 17665323
[No Abstract] [Full Text] [Related]
3. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 1.
Walker K; Kibble A; Shumoogam J
IDrugs; 2007 Aug; 10(8):513-6. PubMed ID: 17665320
[No Abstract] [Full Text] [Related]
4. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
Morgensztern D; Pennell NA; Subramanian J; Govindan R
Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
[TBL] [Abstract][Full Text] [Related]
5. [New antitumor derivatives of vinblastine].
Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C
Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
[TBL] [Abstract][Full Text] [Related]
6. Vinflunine.
Shnyder SD
IDrugs; 2004 Sep; 7(9):851-9. PubMed ID: 15470603
[TBL] [Abstract][Full Text] [Related]
7. American society of clinical oncology - 45th annual meeting. Part 2.
Lakeram M; Kibble A
IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155
[No Abstract] [Full Text] [Related]
8. American society of clinical oncology - 45th annual meeting. Part 1.
Gale S
IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154
[No Abstract] [Full Text] [Related]
9. American Society of Clinical Oncology-39th Annual Meeting. Investigational Drugs. 31 May-3 June 2003, Chicago, IL, USA.
Erlich R; Durrance A
IDrugs; 2003 Jul; 6(7):628-30. PubMed ID: 12906005
[No Abstract] [Full Text] [Related]
10. Glyn Edwards talks about cancer drug development at Antisoma. Interview by Ulrike Knies-Bamforth and Dan Huke.
Edwards G
Drug Discov Today; 2005 Nov; 10(22):1491-4. PubMed ID: 16257369
[TBL] [Abstract][Full Text] [Related]
11. [Coronary disease and vinorelbine].
Ruffenach M; Missler J; Meier M; Salen JM
Rev Pneumol Clin; 1994; 50(2):94. PubMed ID: 7839061
[No Abstract] [Full Text] [Related]
12. Supravenous hyperpigmentation induced by vinorelbine.
Cecchi R; Tuci F; Giomi A; Innocenti F
Dermatology; 1994; 188(3):244. PubMed ID: 8186521
[No Abstract] [Full Text] [Related]
13. American Chemical Society--229th National Meeting. Oncology.
Chan D; Mackonochie M
IDrugs; 2005 Apr; 8(4):280-2. PubMed ID: 15800795
[No Abstract] [Full Text] [Related]
14. From silos to a critical path of new agent development: a paradigm to revolutionize clinical research.
Benson AB
J Clin Oncol; 2008 Apr; 26(12):1924-5. PubMed ID: 18421045
[No Abstract] [Full Text] [Related]
15. The epothilones: how pharmacology relates to clinical utility.
Michaud LB
Ann Pharmacother; 2009 Jul; 43(7):1294-309. PubMed ID: 19584389
[TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology-39th Annual Meeting. Taxanes. 31 May-3 June 2003, Chicago, IL, USA.
Erlich R; Durrance A
IDrugs; 2003 Jul; 6(7):621-2. PubMed ID: 12906002
[No Abstract] [Full Text] [Related]
17. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part II.
Filson S
IDrugs; 2007 Jun; 10(6):359-61. PubMed ID: 17641994
[No Abstract] [Full Text] [Related]
18. Cancer research. Can fasting blunt chemotherapy's debilitating side effects?
Couzin J
Science; 2008 Aug; 321(5893):1146-7. PubMed ID: 18755948
[No Abstract] [Full Text] [Related]
19. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part I.
Kneller S
IDrugs; 2007 Jun; 10(6):356-8. PubMed ID: 17641993
[No Abstract] [Full Text] [Related]
20. Reflections on medical oncology: 25 years of clinical trials--where have we come and where are we going?
Booth CM; Tannock I
J Clin Oncol; 2008 Jan; 26(1):6-8. PubMed ID: 18165630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
